Form D · Biotechnology
PharmaIN Corp
Bothell, WA · CIK 0001608123
Offering snapshot reported May 14, 2014 · SEC filing
- Reported sold
- $1.5M Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 30, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 14, 2014 | Initial | $1,500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-217375
Source: Form D, filed May 14, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Elijah Bolotin | Director, Executive |
| James Foght | Director |
| Tibor Papp | Director |
| John Presutti | Director |
| Lester Salans | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
19805 N. Creek Pkway, Suite 200
Bothell, WA, 98011
Bothell, WA, 98011